Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Broader women’s HRT and longevity care; this record is not classified as peptide-specific. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

An audience-focused care page connects a clear opening with treatment context, the clinician-led process, supporting information and a visit entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The patch photo makes the product the whole scene: a small rectangle on skin shows what HRT actually looks like, which takes the mystery out of it. We treat your symptoms: followed by six chips (hot flashes, sleep issues, brain fog, mood swings, hormonal weight gain, low libido) lets each viewer find her own reason in a glance. The copy is short and warm (you don't have to white-knuckle your way through them), and the headline, Perimenopause, Meet HRT, introduces the two like a match. The insurer strip handles the cost question without a word of copy.
There's no proof in the ad beyond insurer logos, and no detail on what a visit involves. The link description promises a state and insurance carrier check, but the hormone therapy page it lands on doesn't have one, so that promise breaks at the click. If you make one like this, either send the ad to a page with the coverage checker or change the description to what the page offers (a covered first visit, no referral needed), and add a one-line patient quote under the chips.
It states the service and the audience in one line.
The patch shows what treatment looks like, and the chips let viewers find their own symptom.
Logos answer the cost question at a glance.
It frames the introduction and points to a coverage check.
No discount. Visits are framed as covered by insurance, and the description invites a coverage check by state and carrier.
The ad lands on the hormone therapy page, a focused service landing page whose hero (Insurance-covered HRT) sits above the same patch photo, so the visual match is exact. Below, Most major insurance accepted. No referral needed., an HRT 101 section explaining forms and symptoms, safety, form and dosage cards, Start with a virtual visit., a price table (covered or $250 and $150 self-pay) and patient stories follow. The state and carrier checker the ad's description promises isn't on this page.
Midi's hormone therapy page is a focused service landing page: an Insurance-covered HRT hero over a patch photo, a no-referral line, insurer logos, an HRT 101 explainer, safety, form and dosage cards, a virtual visit band, a price table, patient cards and FAQs. It's where 1 Midi ad in the library lands, the Perimenopause, Meet HRT patch static.
Insurance-covered HRT with a line about safely determining if HRT is right for you and a Book now button answers what this is.
A large photo of a patch on a hip answers what treatment looks like.
Most major insurance accepted. No referral needed. and insurer logos answer coverage.
Trusted by 500k+ women and evidence-based care answer whether others trust Midi.
What is HRT?, how it works, its forms and the symptoms it's used for, with citations, answer what I'd actually be taking.
Three cards under Personalized treatment, prescribed by an expert answer whether it's tailored and safe.
Start with a virtual visit. says you'll leave with a plan even if HRT isn't right, answering what if it's not for me.
First and returning visits, covered or $250 and $150 self-pay, with coverage notes answer cost.
Real women. Real results. photo cards and citations answer whether it worked for others.
Seven questions on benefits, safety, timing and hysterectomy, then Meet with an expert clinician today, answer the last doubts.
Read the full breakdown of this page
One of 15 Midi Health ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.